DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,942,000 | -39.0% | 281,569 | -29.6% | 0.08% | -16.8% |
| Q1 2022 | $6,460,000 | -24.6% | 400,000 | 0.0% | 0.10% | -7.3% |
| Q4 2021 | $8,564,000 | +45.7% | 400,000 | 0.0% | 0.11% | +41.6% |
| Q3 2021 | $5,876,000 | -26.1% | 400,000 | 0.0% | 0.08% | -28.0% |
| Q2 2021 | $7,956,000 | -33.5% | 400,000 | 0.0% | 0.11% | -39.5% |
| Q1 2021 | $11,960,000 | – | 400,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,626,476 | $78,771,000 | 38.55% |
| Logos Global Management LP | 2,797,501 | $39,165,000 | 7.18% |
| Cormorant Asset Management, LP | 5,500,000 | $77,000,000 | 5.82% |
| Ghost Tree Capital, LLC | 275,000 | $3,850,000 | 2.00% |
| EcoR1 Capital, LLC | 2,634,178 | $36,878,000 | 1.27% |
| RA Capital Management | 2,186,636 | $30,613,000 | 0.82% |
| Vivo Capital, LLC | 476,589 | $6,672,000 | 0.67% |
| Avoro Capital Advisors LLC | 2,222,222 | $31,111,000 | 0.62% |
| Artal Group S.A. | 400,000 | $5,600,000 | 0.30% |
| Rock Springs Capital Management LP | 460,391 | $6,445,000 | 0.19% |